(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics POC Testing >  New Frontiers in Point-of-Care/POC Infectious Disease Testing: Business Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Point-of-Care/POC Infectious Disease Testing: Business Challenges, Emerging Technologies, Competitive Landscape




New Frontiers in Point-of-Care/POC Infectious Disease Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new report, which provides comprehensive analysis of the  POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of the POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Ambulatory Care Centers        
- Surgery Centers 
- Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Infectious Disease Tests

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus,  Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis (A, B, C, D, E), Herpes Simplex Virus, Human Herpes Virus-6 (HHV-6), Influenza, Legionella, Lyme disease, Pymphogranuloma, Malaria, Measles, Meningitis, Mononucleosis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Polyomaviruses, Parvovirus B19, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rheumatoid Arthritis, Rotavirus , Rubella, Salmonellosis, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, Tuberculois, Vibrio, West Nile, Yersenia.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies
  and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially
  significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product
  portfolios, marketing tactics, joint ventures, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott
   - Affymetrix
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - Biomerieux
   - Bio-Rad
   - Cepheid       
   - Diamedix           
   - Diasorin
   - Eiken Chemical
   - Enzo Biochem
   - Fujirebio/Innogenetics
   - Grifols/Novartis Diagnostics
   - Hologic/Gen-Probe
   - ID Biomedical/GSK
   - Kreatech
   - Lonza
   - Nanogen/Elitech
   - Ortho-Clinical Diagnostics
   - Qiagen
   - Roche
   - Scienion
   - Sequenom
   - SeraCare
   - Siemens
   - Takara Bio
   - ThermoFisher/Life Technologies
   - Wallac/PE
   - Wako
  
Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.

Contains 835 pages and 80 tables



To order sections of this report, contact Client Services


     
   
Local PDF: $8500.00
Other Formats: Global PDF, DataPack
   
   
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X